(Q53321831)

13 May 2018

title

Trans-species comparison of PPAR and RXR expression by rat and human urothelial tissues. (English)

1 reference

13 May 2018

author

Jennifer Southgate

4

1 reference

13 May 2018

Bikramjit Chopra

object named as

Bikramjit Chopra

1

0 references

author name string

Jennifer Hinley

2

1 reference

13 May 2018

Martin B Oleksiewicz

3

1 reference

13 May 2018

language of work or name

English

0 references

publication date

25 April 2008

1 reference

13 May 2018

published in

Toxicologic Pathology

1 reference

13 May 2018

volume

36

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

485-495

1 reference

13 May 2018

The mechanisms of action of PPARs

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Dual PPARalpha /gamma activation provides enhanced improvement of insulin sensitivity and glycemic control in ZDF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Evolution of peroxisome proliferator-activated receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Effects of PPARgamma and combined agonists on the urinary tract of rats and other species

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

The mammalian urinary bladder: an accommodating organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5'-flanking region

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Roles of PPARs in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Can thiazolidinediones delay disease progression in type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

(-)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: a dual PPAR agonist with potent antihyperglycemic and lipid modulating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Urothelial progenitor cells: regional differences in the rat bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Generalized cellular hypertrophy is induced by a dual-acting PPAR agonist in rat urinary bladder urothelium in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Therapeutic roles of peroxisome proliferator-activated receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Urothelial differentiation in chronically urine-deprived bladders of patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Rodent carcinogenicity profile of the antidiabetic dual PPAR alpha and gamma agonist muraglitazar.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

PPARgamma-regulated tight junction development during human urothelial cytodifferentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Autocrine regulation of human urothelial cell proliferation and migration during regenerative responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Peroxisome proliferator-activated receptor alpha and gamma ligands differentially affect smooth muscle cell proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

Activation of peroxisome proliferator-activated receptors alpha and gamma1 inhibits human smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

PPARβ/δ Regulates Paneth Cell Differentiation Via Controlling the Hedgehog Signaling Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623308315672

21 January 2018

Identifiers

DOI

10.1177/0192623308315672

1 reference

13 May 2018

1 reference

13 May 2018